Skip to content Skip to footer

Research Portal of the TU Dresden

The Lancet

ISSNs: 0140-6736

Additional searchable ISSN (electronic): 1474-547X

Elsevier Science B.V.

Scopus rating (2024): CiteScore 87.6 SJR 12.113 SNIP 22.724

Journal

Titles	The Lancet Lancet
Additional searchable titles	LANCET, Lancet (London, England), Lancet.
ISSNs	0140-6736
Additional searchable ISSN (electronic)	1474-547X
Publisher	Elsevier Science B.V.
ZDB-ID	3306-6
ZDB-ID	339572-8
ZDB-ID	1476593-7

Keywords

ASJC Scopus subject areas

Medicine (all)

Library keywords

610 Medicine and health

Related content

Research output

Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis

ATTENTION, BASICS, BAOCHE, and BEST Investigators, Nogueira, R. G., Jovin, T. G., Liu, X., Hu, W., Langezaal, L. C. M. & Li, C. & 26 others, Dai, Q., Tao, C., Mont'Alverne, F. J. A., Ji, X., Liu, R., Li, R., Dippel, D. W. J., Wu, C., Zhu, W., Xu, P., van Zwam, W. H., Wu, L., Zhang, C., Michel, P., Chen, J., Wang, L., Puetz, V., Zhao, W., Liu, T., Audebert, H. J., Chen, Z., Pontes-Neto, O. M., Yi, T., Moran, T. P., Doheim, M. F. & Schonewille, W. J., 4 Jan 2025, In: The Lancet. 405, 10472, p. 61-69 9 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

QUASAR Study Group, Rubin, D. T. & Petrov, A., 4 Jan 2025, In: The Lancet. 405, 10472, p. 33-49 17 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up

MCS Collaborator Scientific Group, 14 Sept 2024, In: The Lancet. 404, 10457, p. 1019-1028 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

German Hodgkin Study Group, Hänel, M. & Trautmann-Grill, K., 27 Jul 2024, In: The Lancet. 404, 10450, p. 341-352 12 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial

LANDMARK trial investigators, 22 Jun 2024, In: The Lancet. 403, 10445, p. 2695-2708 14 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (40)